Expression of matrix metallproteinases and their tissue inhibitors in mitral valve with rheumatic heart disease

王栋,胡建才,苏莉,朱水波,殷桂林,王荣平,张晓明,郗二平
DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.06.034
2008-01-01
Abstract:Objective To explore the pathological role and mechanisms of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in mitral valve of patients with rheumatic heart disease (RHD).Methods Experimental group was composed of 16 samples of rheumatic mitral valves,while control group consisted of 7 normal mitral valves from adults who were died accidentally without cardiovascular diseases.Tissue samples were investigated by hematoxylin and eosin stain,reverse transcription polymerase chain reaction (RT-PCR),immunohistochemistry and transmission electron microscopy (TEM).Results Pathological figures and microstructures of rheumatic transformation in experimental group were showed dramatically,while the structures were basically normal in control group.The expression levels of MMP-2,13 and TIMP-1,2 mRNA were increased significantly in RHD group compared with control group (P<0.05).Conclusion The up-regulation of the expression of MMPs/TIMPs system may involved in the remodeling of extracellular matrix of mitral valve,and may be one of the important molecular mechanisms in its rheumatic pathologic developing process.
What problem does this paper attempt to address?